Shareholders in Swiss pure-play dermatology company Galderma have raised CHF1.34bn (US$1.5bn) in a secondary sale this week, say reports. Some 15 million shares were sold at CHF89 per share. The…
Switzerland: Galderma share sale raises CHF1.34bn despite choppy markets
…
…






